A new role of SGLT-2 - treatment of IgA-nephropathy?
Sodium Glucose co-transporter 2 inhibitors (SGLT2) paved their way into traditional science books less than a decade ago as a new class of drugs treating diabetes. However, the ongoing discovery of their ever-widening array of uses shows that we are still yet to tap into their full potential. SGLT2...
Main Authors: | Syeda Zeenat Sahar Junaid, Muhammad Muntazir Mehdi Khan, Henna Fatma |
---|---|
Format: | Article |
Language: | English |
Published: |
Pakistan Medical Association
2022-12-01
|
Series: | Journal of the Pakistan Medical Association |
Online Access: | https://www.ojs.jpma.org.pk/index.php/public_html/article/view/7076 |
Similar Items
-
Effect of SGLT2 inhibitors on the proteinuria reduction in patients with IgA nephropathy
by: Yaping Dong, et al.
Published: (2023-09-01) -
Role of telitacicept in the treatment of IgA nephropathy
by: Lijun Wu, et al.
Published: (2023-09-01) -
IgA Nephropathy: Current Treatment and New Insights
by: Dimitra Petrou, et al.
Published: (2023-06-01) -
IgA Vasculitis and IgA Nephropathy: Same Disease?
by: Evangeline Pillebout
Published: (2021-05-01) -
Immunosupression in IgA Nephropathy
by: Ileana Peride, et al.
Published: (2022-03-01)